Drug Shortage Report for SANDOZ LOSARTAN HCT

Last updated on 2020-08-17 History
Report ID 73158
Drug Identification Number 02313375
Brand name SANDOZ LOSARTAN HCT
Common or Proper name LOSARTAN HCT
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM
Strength(s) 12.5MG 50MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-10-29
Estimated end date 2020-08-07
Actual end date 2020-08-07
Shortage status Resolved
Updated date 2020-08-17
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v20 2020-08-17 French Compare
v19 2020-08-17 English Compare
v18 2020-07-06 French Compare
v17 2020-07-06 English Compare
v16 2020-06-29 French Compare
v15 2020-06-29 English Compare
v14 2020-06-22 French Compare
v13 2020-06-22 English Compare
v12 2020-05-19 French Compare
v11 2020-05-19 English Compare
v10 2020-05-11 French Compare
v9 2020-05-11 English Compare
v8 2020-05-04 French Compare
v7 2020-05-04 English Compare
v6 2020-04-06 French Compare
v5 2020-04-06 English Compare
v4 2020-03-30 French Compare
v3 2020-03-30 English Compare
v2 2019-01-22 French Compare
v1 2019-01-22 English Compare